Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

3D printing is a manufacturing game-changer

Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...
Richard (Rick) Mills | November 15, 2019 |

NU Skin Shares Climb 25% Higher on Strong Quarterly Global Customer and Revenue Growth

NU Skin Enterprises reported that preliminary Q2/20 revenue exceeded previously forecasted estimates and that the company is experiencing stronger than expected global growth along with accelerated digital adoption. Direct selling company NU Skin Enterprises Inc. ...
Streetwise Reports | July 3, 2020 |

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
Streetwise Reports | December 5, 2019 |

Unique Value-Added Antiviral Vaccine Technology Platform

(Click to play video.) Founded in 2018 to improve on protein haptenization and leverage previous vaccine development in the field, Vancouver, BC-based BioVaxys Technology Corp . ( CSE.BIOV , OTCQB: BVAX , Forum ) is a clinical stage biotechnology company that...
Dave Jackson | September 14, 2021 |

Ballard Power, NVIDIA, SolGold - copper, processors and fuel cells for the portfolio

The mobility of the future will be diverse. In addition to internal combustion engines, vehicles with electric motors will also define future everyday life. This politically motivated development will be supported by subsidies and premiums in various areas. Investors who would...
Mario Hose | August 27, 2020 |

Trillion-dollar US infrastructure plan will draw in plenty of metal

Donald Trump appears to have torn a page from Ahead of the Herd’s manual for recharging the US economy. In an earlier article we said what the global economy really needs, in this low-growth, spending-stalled environment brought about by the pandemic, is...
Richard (Rick) Mills | June 19, 2020 |

Three COVID-19 Patients Treated with PLX Cells

Two programs, one new and the other ongoing, involving Pluristem Therapeutics' regenerative products are reviewed in a Dawson James report. In a March 30 research note, Dawson James Securities analyst Jason Kolbert reported that three high-risk COVID-19 pati...
Streetwise Reports | April 2, 2020 |

Simple, Uncomplicated: Find Out What Natural Beauty is All About

(Click image to play video) 2020 has been a whirlwind year for Marianna Naturals Corp. ( MRNN , Forum ). Founded in April of 2020 by both Co-Founder & Chairwoman Heather Marianna and Co-Founder, President & CEO Joel DeBellefeuille as the company is ...
Dave Jackson | February 4, 2021 |

Paratek Pharma Awarded $285 Million BARDA Contract to Combat Anthrax

Shares of Paratek Pharmaceuticals traded 40% higher today after the firm announced it was awarded a BARDA BioShield program contract valued at up to $285 million for NUZYRA used to treat anthrax. Late yesterday afternoon, biopharmaceutical company Paratek Pharmaceuti...
Streetwise Reports | December 20, 2019 |

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...
Ryan Dhillon | January 22, 2024 |
1 2 3 4 5 6 7 8 9 10 ...